Hostname: page-component-74656f9884-skzmx Total loading time: 0 Render date: 2026-11-06T12:34:11.460Z Has data issue: false hasContentIssue false

Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria

Published online by Cambridge University Press:  20 April 2007

L. XIE
Affiliation:
Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
Q. LI*
Affiliation:
Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
J. JOHNSON
Affiliation:
Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
J. ZHANG
Affiliation:
Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
W. MILHOUS
Affiliation:
Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
D. KYLE
Affiliation:
Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
*
*Corresponding author. Tel: 001 301 319 9351. Fax: 001 301 319 7360. E-mail: qigui.li@na.amedd.army.mil
Rights & Permissions [Opens in a new window]

Summary

An automated flow cytometric (FCM) detection method has been developed and validated with a simple diagnostic procedure in parasitized erythrocytes of Plasmodium berghei-infected rats using the nucleic acid-binding fluorescent dye YOYO-1. High levels of reticulocytes were detected during the course of the infection, ranging from 1·2–51·2%, but any RNA potentially confounding the assay could be removed by digestion with RNAse. The cell counts of uninfected, infected, and nucleated cells occurred with high precision. The cells were divided into different populations according to their physical or chemical properties but various factors within the assay such as cell fixation, RNA digestion, and compensation required optimization. In this study, FCM greatly simplified and accelerated parasite detection, with a mean precision of 4·4%, specificity of 98·9% and accuracy of 101·3%. The detection and quantitation limits in the assay were 0·024% and 0·074% parasitaemia, respectively. Overall, the parasite counts by FCM measurement correlated highly (r2=0·954–0·988) with the parasitaemia measured by light microscopical analysis when animals treated with suppressive, clearance, and curative doses of novel antimalarial drugs were examined. The lower levels of parasitaemia (30%) detected by microscopy compared to FCM may be related to a number of schizonts externally attached to the erythrocyte membranes that normally would not be included in microscopy counting. Lower sampling error and reliable identification of rodent erythrocyte parasites based on the principles of FCM have replaced the traditional blood smear in our laboratory.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007
Figure 0

Fig. 1. Flow cytometry analysis of erythrocytes and nucleated blood cells of YOYO-1 stained with bivariate graphs (YOYO-1/FL2) from uninfected (A) or Plasmodium berghei-infected rats with (B). A1: Uninfected blood with RNAse shows RBC as a green population, nucleated WBC and lymphocytes in the black and purple regions, respectively, and reticulocytes in the orange region (0·03%). A2: Same uninfected blood without RNAse shows 5·6% of reticulocytes as orange population. B1: Infected blood with RNAse exhibited 19·2% parasitaemia at day 8 after infection. B2: Same infected sample (B1) without RNAse exhibited 31·8% parasitaemia plus reticulocytes. B3 and B4: Complete separation of the three regions or populations of the sample (B3) in region 1 (uninfected RBC, green population), 2 (infected parasitaemia, orange population), and 3 (nucleated cells, black and purple populations) by a bidimensional analysis of YOYO-1 fluorescent intensity.

Figure 1

Fig. 2. Assessment of the optimum concentrations of glutaraldehyde as a fixative agent for FCM using YOYO-1 staining is shown for RBC. Sample blood from Plasmodium berghei-infected rats was fixed with increasing concentrations of glutaraldehyde. The figure demonstrates that haemolysis of RBC is increased (empty circle and solid-line) at low glutaraldehyde concentrations. The YOYO-1 fluorescence intensity in intervals between the cell peaks from region 1 (uninfected RBC in green colour) to region 2 (infected RBC in orange colour) populations (triangle and dashed-line) (Fig. 1) is increased and decreased at low and high, respectively, glutaraldehyde concentrations. The sample shown was fixed at the optimal glutaraldehyde concentration (0·04%, vertical dashed line), which keeps haemolysis to a minimum whilst maintaining the widest possible separation (intensity) between the two regions in the present study.

Figure 2

Fig. 3. Optimal resolution achieved and regions deployed to calculate mean fluorescence intensity from the YOYO-1 positive population (infected RBC and nucleated cells) with respect to uninfected RBCs. Bidimensional analysis of YOYO-1 fluorescent intensity of samples from Plasmodium berghei-infected rats with increasing concentrations of glutaraldehyde (A–C). A1–2: at low concentration (0·0125%) of glutaraldehyde, a clear separation (long distance) between the region 1 (green in A1 or blue in A2) and region 2 (orange) populations is displayed but with high percentage (31·3%) of haemolysis; B1–2: at middle concentration (0·05%) there still is good separation (short distance) between the two regions with light haemolysis (8·8%) occurring; C1–2: at high level (0·2%) of glutaraldehyde there is significantly no separation between the two regions and no haemolysis (0%).

Figure 3

Fig. 4. Sensitivity of detection from calibration curves of Plasmodium berghei-infected erythrocytes from 4 separate rats. Parasites counted by flow cytometry were compared with the parasitaemia calculated from the initial parasitaemia and the dilution factor. The detection limit (DL) and quantitative limit (QL) were determined from the background using the bidimensional FL-1 (YOYO-1)/FL-2 method with the decimal logarithm of the mean of duplicate samples for each dilution tested (n=4).

Figure 4

Table 1. Assay of linearity of the flow cytometry method on lower parasitaemia (0·05–0·60%) and higher parasitaemia (1·2–18%) samples by calibration curves(The calibration curve was linearly fitted and weighted by 1/concentration with examination of the correlation coefficient, n=4.)

Figure 5

Table 2. Accuracy and precision assessments of parasitaemias from individual Plasmodium berghei-infected rats by using validation analysis via the reproducibility of a single sample stained and analysed in duplicate at least 10 times(Accuracy: 100% measured parasitaemia/nominal parasitaemia from flow cytometry or microscopy methods; FCM: flow cytometry.)

Figure 6

Fig. 5. Photomicrographs of Plasmodium berghei-infected rat erythrocytes at day 5 post-infection. (A and B) Light microscopy with Giemsa-stained blood smears. Arrows identify schizonts penetrating or re-invading the RBC on its membrane surface (A1 and B1), and Giemsa-stained nuclei in the schizonts (A2 and B2). (C–E) Fluorescent microscopy. Arrows are used to identify the schizonts on the erythrocyte surface membrane. We consider that these (pre-infection) parasites are attached to, but definitely not inside the erythrocyte. In our laboratory such cells would never be included in a parasitaemia count determined by microscopy but could well be measured by FCM.

Figure 7

Fig. 6. Correlations (r2=0·954–0·988) are shown between flow cytometry and microscopical determination of parasitaemia in Plasmodium berghei-infected rats treated with the following antimalarial drugs or control. Samples (markers) were taken from the vehicle control group in 4 rats (A), treatment group with intravenous artesunate at 50 mg/kg showing suppression effect (re-plot graph) in 4 rats (B), treatment group with intravenous artesunate at 100 mg/kg showing clearance effect (re-plot graph) in 4 rats (C), and treatment group with oral pyrroloquinazolinediamine at 10 mg/kg showing curative effect (re-plot graph) in 2 rats (D). The line represents linear regression whose statistical parameters are shown in the inset (A–D). The control animals received vehicle and the treatment animals received drugs at daily intervals on day 6–8 post-infection with P. berghei.